TH1579 (MTH1 inhibitor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TH1579 (MTH1 inhibitor), covering 2025-09-09 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: MTH1, A Phase I, Study on Tumors Inhibition, First in Human, First in Class [Phase 1]